摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide | 162808-62-0

中文名称
——
中文别名
——
英文名称
N-[(6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide
英文别名
——
N-[(6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide化学式
CAS
162808-62-0
化学式
C52H88N10O15
mdl
——
分子量
1093.3
InChiKey
JYIKNQVWKBUSNH-HDVLJZKUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    1408.1±65.0 °C(Predicted)
  • 密度:
    1.36±0.1 g/cm3(Predicted)
  • 溶解度:
    In water, 28 mg/L at 25 °C (est)

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    77
  • 可旋转键数:
    23
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    412
  • 氢给体数:
    16
  • 氢受体数:
    18

ADMET

代谢
通过解和N-乙酰化缓慢代谢;同时发生自发的化学降解并进一步解为构成氨基酸及其降解产物,包括二羟基同酪氨酸和N-乙酰二羟基同酪氨酸
Slowly metabolized by hydrolysis and N-acetylation; also undergoes spontaneous chemical degradation and further hydrolysis to constitutive amino acids and their degredates, including dihydroxyhomotyrosine and N-acetyl-dihydroxyhomotyrosine.
来源:Hazardous Substances Data Bank (HSDB)
代谢
卡泊芬净在肝脏中通过解和N-乙酰化缓慢代谢;单次静脉注射放射性标记剂量后,分别有35%和41%的母药和代谢物通过粪便和尿液排出。
Caspofungin is slowly metabolized in the liver via hydrolysis and N-acetylation; 35 and 41% of the parent drug and metabolites were excreted in feces and urine, respectively, following a single IV radiolabeled dose.
来源:Hazardous Substances Data Bank (HSDB)
代谢
研究了小鼠、大鼠、兔和猴单次静脉注射卡泊芬净后的代谢、排泄和药代动力学。...在所有研究物种中,放射性物质的排泄速度都较慢,在整个延长的收集期内,每日尿液和粪便样本中都能检测到低平的放射性物质。尽管尿液轮廓表明存在多种代谢物(M0、M1、M2、M3、M4、M5和M6),但大部分总放射性物质与极性代谢物M1 [4(S)-羟基-4-(4-羟基苯基)-L-苏氨酸]和M2(N-乙酰-4(S)-羟基-4-(4-羟基苯基)-L-苏氨酸)有关。因此,卡泊芬净主要通过代谢转化消除;然而,代谢速率较慢。...
The metabolism, excretion, and pharmacokinetics of caspofungin were investigated after administration of a single intravenous dose to mice, rats, rabbits, and monkeys. ... Excretion of radioactivity in all species studied was slow, and low levels of radioactivity were detected in daily urine and fecal samples throughout a prolonged collection period. Although urinary profiles indicated the presence of several metabolites (M0, M1, M2, M3, M4, M5, and M6), the majority of the total radioactivity was associated with the polar metabolites M1 [4(S)-hydroxy-4-(4-hydroxyphenyl)-L-threonine] and M2 (N-acetyl-4(S)-hydroxy-4-(4-hydroxyphenyl)-L-threonine). Caspofungin was thus primarily eliminated by metabolic transformation; however, the rate of metabolism was slow. ...
来源:Hazardous Substances Data Bank (HSDB)
代谢
卡泊芬净通过解和N-乙酰化缓慢代谢。卡泊芬净还会自发化学降解为开环肽化合物L-747969。在较晚的时间点(≥5天剂量后),单次给药(3)H卡泊芬净醋酸酯后在血浆中存在低平的(≤7皮摩尔/毫克蛋白,或≤1.3%的给药剂量)放射性标记的共价结合,这可能是由于卡泊芬净降解为L-747969时形成的两个反应中间体。额外的代谢涉及解成构成氨基酸及其降解物,包括二羟基同